Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
US8742076B2 · kind B2 · utility
25Cited by
11References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2009 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Apr 16, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibody-drug conjugate compounds of Formula I:Ab-(L-D)p I
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.